MARKET

GSK

GSK

GSK PLC
NYSE
36.35
-1.02
-2.73%
After Hours: 36.55 +0.2 +0.55% 18:53 05/13 EDT
OPEN
36.68
PREV CLOSE
37.37
HIGH
36.69
LOW
36.17
VOLUME
5.08M
TURNOVER
--
52 WEEK HIGH
44.37
52 WEEK LOW
31.37
MARKET CAP
74.63B
P/E (TTM)
18.47
1D
5D
1M
3M
1Y
5Y
1D
BUZZ-iTeos rises as it looks to conserve cash after cancer drug setback
Reuters · 4h ago
iTeos Therapeutics downgraded to Neutral at JPMorgan after TIGIT program ended
TipRanks · 4h ago
Bernstein Sticks to Its Buy Rating for GlaxoSmithKline (GSK)
TipRanks · 10h ago
GSK, iTeos end lung cancer asset development after trial failure
Seeking Alpha · 10h ago
Medicare to publish drugs selected for third round of price negotiations by Feb. 1
Seeking Alpha · 10h ago
GSK, iTeos ending development program for belrestotug
TipRanks · 10h ago
iTeos Therapeutics, GSK agree to terminate belrestotug development program
TipRanks · 10h ago
iTeos: GALAXIES Lung-201 did not meet criteria for meaninful improvements in PFS
TipRanks · 10h ago
More
About GSK
More
GSK plc is a global biopharma company. The Company’s segments include Commercial Operations and Research and Development. Its portfolio and pipeline are focused on developing medicines and vaccines in four core therapeutic areas, which are the areas of human health it focuses on to prevent and treat disease: respiratory, immunology and inflammation; oncology; HIV; and infectious diseases. Its specialty medicines prevent and treat diseases, from human immunodeficiency virus (HIV) to respiratory diseases, immune-mediated conditions like lupus, and cancer. Its vaccine portfolio includes over 20 vaccines that help to protect people from a range of diseases and infections throughout their lives. General medicines include inhaled medicines for asthma and COPD, antibiotics and medicines for skin diseases. Its portfolio also includes the lead molecule IDRX-42, highly selective tyrosine kinase inhibitor (TKI) that is designed to improve patients with gastrointestinal stromal tumors (GIST).
Recently
Symbol
Price
%Change

Webull offers GSK plc (ADR) stock information, including NYSE: GSK real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GSK stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GSK stock methods without spending real money on the virtual paper trading platform.